Connor, Clark & Lunn Investment Management (CC&L)’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.1M | Sell |
|
|||||
|
2025
Q4 | $12.1M | Sell |
|
|||||
|
2025
Q3 | $15M | Sell |
|
|||||
|
2025
Q2 | $7.4M | Sell |
|
|||||
|
2025
Q1 | $4.25M | Sell |
|
|||||
|
2024
Q4 | $4.78M | Buy |
|
|||||
|
2024
Q3 | $2.85M | Buy |
|
|||||
|
2024
Q2 | $1.18M | Buy |
|
|||||
|
2024
Q1 | $1.5M | Buy |
|
|||||
|
2023
Q4 | $3.78M | Buy |
|
|||||
|
2023
Q3 | $2.28M | Buy |
|